Kim Thacker, MD, MS
Senior Vice President, Medical Affairs and Clinical Innovation at Brainstorm Cell Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Native or bilingual proficiency
-
French Limited working proficiency
-
Italian Limited working proficiency
Topline Score
Bio
Experience
-
Brainstorm Cell Therapeutics
-
Israel
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Vice President, Medical Affairs and Clinical Innovation
-
Nov 2021 - Present
-
-
-
American Tap Dance Foundation
-
United States
-
Performing Arts
-
1 - 100 Employee
-
Board Chair/President
-
Jul 2019 - Present
ATDF is a non profit organization committed to establishing and legitimizing Tap Dance as a vital component of American dance through creation, presentation, education and preservation. Board activities include oversight of annual budget, planning fundraising activities and contributing to ATDF strategic mission. ATDF is a non profit organization committed to establishing and legitimizing Tap Dance as a vital component of American dance through creation, presentation, education and preservation. Board activities include oversight of annual budget, planning fundraising activities and contributing to ATDF strategic mission.
-
-
-
UroGen Pharma
-
United States
-
Biotechnology
-
100 - 200 Employee
-
Vice President Medical Affairs
-
Jul 2019 - May 2021
Developed strategy and executed Medical Affairs plan to achieve the successful launch of our first commercialized product for low-grade upper tract urothelial cancer, including KOL engagement, HEOR and value work, robust publication plan and payer presentations. Prepared groundwork for products in development for bladder cancer. Developed strategy and executed Medical Affairs plan to achieve the successful launch of our first commercialized product for low-grade upper tract urothelial cancer, including KOL engagement, HEOR and value work, robust publication plan and payer presentations. Prepared groundwork for products in development for bladder cancer.
-
-
-
Turing Pharmaceuticals AG
-
New York, NY
-
Vice President, Head of Medical Affairs
-
Jun 2015 - Sep 2015
Build and create a Medical Affairs department to support product launches and products currently in development. Create medical strategies for commercialization of products including Phase IV studies. Build and create a Medical Affairs department to support product launches and products currently in development. Create medical strategies for commercialization of products including Phase IV studies.
-
-
-
Mesoblast Limited
-
Australia
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President Medical Affairs
-
Jul 2014 - Jun 2015
Development and creation of Medical Affairs department to support the stem cell clinical product pipeline derived from Mesoblast's proprietary Mesenchymal Cell Lineage technology platforms. Therapeutic areas under investigation include diseases with an inflammatory and immunology etiology, cardiac/vascular, orthopedic disease of the spine and oncology. Activities include preparing for commercialization and launch of stem cell product, developing strategies and processes and building a Medical Affairs team from the ground up. Show less
-
-
-
Forest Research
-
United States
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
-
2006 - 2013
Responsible for all Medical Affairs activities across all therapeutic areas (psychiatry, pain, rheumatology, neurology, cardiology, GI, infectious disease, diabetes, respiratory and others), including promotional review, publications, medical information, Medical Science Liaisons, grant review and approval-both Investigator Initiated Trials and CME, and responsible for Health Economics and Outcomes Research activities. Led the entire department of approximately 90 employees and 5 different functions. Accomplishments per year included over 470 publications, 4000 face-to-face external expert interactions, medical review of nearly 2000 promotional pieces, over 29,000 Medical Information inquiries, over 160 HEOR publications and 150 active IIT grants resulting in over 45 publications. Show less
-
-
-
2006 - 2009
Strategic development and oversight of medical affairs activities across all therapeutic areas in Forest's portfolio
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
VP CNS, Medical Affairs
-
2004 - 2006
Responsible for all medical activities across CNS products with focus on sleep and ALS. Winner of the Pinnacle Award-highest and most prestigious award and only medical professional to receive this award that year. Responsible for all medical activities across CNS products with focus on sleep and ALS. Winner of the Pinnacle Award-highest and most prestigious award and only medical professional to receive this award that year.
-
-
-
-
VP CNS Medical Affairs
-
2003 - 2006
Responsible for all medical activities for CNS products with a focus on Ambien, Ambien CR and Rilutek. Winner of the Pinnacle Award-highest and most prestigious award given at sanofi-aventis Responsible for all medical activities for CNS products with a focus on Ambien, Ambien CR and Rilutek. Winner of the Pinnacle Award-highest and most prestigious award given at sanofi-aventis
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Director, Worldwide Drug Safety
-
2001 - 2003
Supported pharmacovigilance and risk management activities Supported pharmacovigilance and risk management activities
-
-
-
Roche
-
Switzerland
-
Biotechnology Research
-
700 & Above Employee
-
Medical Director
-
1998 - 2001
Medical lead for CNS and chronic care products Medical lead for CNS and chronic care products
-
-
Education
-
Columbia University in the City of New York
Master of Science - MS, Bioethics/Medical Ethics -
State University of New York Downstate Medical Center College of Medicine
Doctor of Medicine (M.D.), Medicine -
Trinity College-Hartford
BS, Biology